JPH0479964B2 - - Google Patents
Info
- Publication number
- JPH0479964B2 JPH0479964B2 JP61015900A JP1590086A JPH0479964B2 JP H0479964 B2 JPH0479964 B2 JP H0479964B2 JP 61015900 A JP61015900 A JP 61015900A JP 1590086 A JP1590086 A JP 1590086A JP H0479964 B2 JPH0479964 B2 JP H0479964B2
- Authority
- JP
- Japan
- Prior art keywords
- hydroxylapatite
- temperature
- calcium phosphate
- solution
- alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 29
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 29
- 239000001506 calcium phosphate Substances 0.000 claims description 20
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 20
- 235000011010 calcium phosphates Nutrition 0.000 claims description 20
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 20
- 239000002244 precipitate Substances 0.000 claims description 12
- 239000003513 alkali Substances 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 229940061607 dibasic sodium phosphate Drugs 0.000 claims description 5
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000002245 particle Substances 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 229920001222 biopolymer Polymers 0.000 description 5
- 244000309466 calf Species 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 4
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Description
【発明の詳細な説明】
(1) 発明の目的
[産業上の利用分野]
本発明は水溶液中の化学成分、特に蛋白質、核
酸その値の生体高分子物質の分離、精製の用に供
する分離用ハイドロキシルアパタイト
(Hydroxylapatite)Ca10(PO4)6(OH)2の製法に
関するものである。[Detailed Description of the Invention] (1) Purpose of the Invention [Field of Industrial Application] The present invention is a method for separating and purifying biopolymer substances such as chemical components in aqueous solutions, especially proteins and nucleic acids. This invention relates to a method for producing hydroxylapatite Ca 10 (PO 4 ) 6 (OH) 2 .
[従来の技術]
蛋白質、核酸などの生体高分子物質の混合水溶
液中からそれらを単離する方法として、固体粒子
に吸脱着せしめる方法が検討され、各種性能の分
離用固体粒子が考案提供されてきている。[Prior Art] As a method for isolating biopolymer substances such as proteins and nucleic acids from a mixed aqueous solution, a method of adsorbing and desorbing them onto solid particles has been studied, and solid particles for separation with various performances have been devised and provided. ing.
チセリウスと彼の共同研究者は1956年、塩化カ
ルシウム溶液と第二燐酸ナトリウム溶液とを室温
(25℃付近)で混合して得られる燐酸カルシウム
沈殿をアルカリ中で煮沸してハイドロキシルアパ
タイトを調製し、これが生体高分子混合液から各
成分を分離精製するのに有用なことを示した。
[エイ・チセリウス、エス・ヒエールテン、エ・
レヴイン;アーカイヴズ オブ バイオケミスト
リイ アンド バイオフイズイツクス(A.
Tiselius,S.Hjerten and O.Levin;Archives
of Biochemistry and Biophysics)65巻、132〜
155頁1956年]
[発明が解決しようとする問題点]
チセリウス等の方法による分離用ハイドロキシ
ルアパタイトは生体高分子の分離精製に利用され
てきているが、ガラス円筒その他のカラムに充填
してカラムクロマトグラフに供した場合、その粒
子径が微小なため流速が極めて遅いことが難点で
ある。これを解決するため、従来は、セルロース
粒子を混合して使用したり、或いは中間体の燐酸
カルシウムを生成させる際、シリカを核として使
用するとか、アルカリ煮沸に際してPHを一定に維
持することなどが行われてきた。しかし、これら
はいずれも操作が煩雑であり、また、必ずしも報
告通りの結果は得られず、充分な改良はなされて
きていなかつたものである。 Ciselius and his collaborators prepared hydroxylapatite in 1956 by boiling the calcium phosphate precipitate obtained by mixing calcium chloride solution and dibasic sodium phosphate solution at room temperature (around 25°C) in alkali. It was shown that this method is useful for separating and purifying each component from a biopolymer mixture.
[A. Ciselius, S. Hierten, E.
Levin; Archives of Biochemistry and Biophysics (A.
Tiselius, S. Hjerten and O. Levin; Archives
of Biochemistry and Biophysics) Volume 65, 132~
155 pages, 1956] [Problems to be solved by the invention] Hydroxylapatite for separation by the method of Chiselius et al. has been used for the separation and purification of biopolymers, but it is difficult to fill it into a glass cylinder or other column. When subjected to chromatography, the problem is that the flow rate is extremely slow due to the small particle size. To solve this problem, conventional methods have been to mix cellulose particles, use silica as a core when producing intermediate calcium phosphate, or maintain a constant pH during alkaline boiling. It has been done. However, all of these methods are complicated to operate, do not always produce the results as reported, and have not been sufficiently improved.
(2) 発明の構成
[問題点を解決するための手段]
本発明者は上記難点を解決することを目的と
し、チセリウス等の方法の各段階を改めて詳細に
検討した結果、粒子径の遥かに大きいハイドロキ
シルアパタイトを調製する特別の条件を発見し、
本発明を完成するに至つた。(2) Structure of the Invention [Means for Solving the Problems] With the aim of solving the above-mentioned difficulties, the present inventor has reexamined in detail each step of the method of Ciselius et al. Discovered special conditions for preparing large hydroxylapatite,
The present invention has now been completed.
即ち、チセリウス等の方法ではハイドロキシル
アパタイトに導く前駆体としての燐酸カルシウム
沈殿を調製するため、塩化カルシウム(CaCl2)
と第二燐酸ナトリウム(Na2HPO4)のそれぞれ
の水溶液を室温(25℃付近)で直接混合していた
が、本発明者は25℃から100℃に至る広い範囲に
わたつて温度を変えて実験し、その影響を検討し
た結果、0.5モルNaCl水溶液に両液を注入して反
応せしめることにより、40〜50℃及び90〜100℃
の二つの温度範囲の条件において塩化カルシウム
溶液と第二燐酸ナトリウム溶液とが混合された場
合、得られた燐酸カルシウム沈殿の粒子サイズは
直径60ミクロン乃至それ以上となり、他の温度領
域に比べて格段に大きく、そしてこれからアルカ
リ中での加熱によつて導かれるハイドロキシルア
パタイトも同様の大きな粒子径を保ち、カラムク
ロマトグラフにおいて従来法によるハイドロキシ
ルアパタイトに可能な展開溶出液流速の10倍に及
ぶ流速が可能となつた。 That is, in the method of Chiselius et al., calcium chloride (CaCl 2 ) is used to prepare calcium phosphate precipitate as a precursor leading to hydroxylapatite.
Aqueous solutions of and dibasic sodium phosphate (Na 2 HPO 4 ) were directly mixed at room temperature (around 25°C), but the inventors changed the temperature over a wide range from 25°C to 100°C. As a result of experimenting and examining the effects, we found that by injecting both solutions into a 0.5M NaCl aqueous solution and allowing them to react, we found that
When calcium chloride solution and dibasic sodium phosphate solution are mixed under the conditions of two temperature ranges, the particle size of the resulting calcium phosphate precipitate is 60 microns or more in diameter, which is much larger than in other temperature ranges. Hydroxylapatite, which will be derived by heating in an alkali, will maintain a similar large particle size, and in column chromatography, the flow rate of the developing eluate that is 10 times higher than that possible for hydroxylapatite using conventional methods. became possible.
上記現象は本発明者も当初全く予想しなかつた
ところであるが、この結果から、その生成機作は
次の如く考えられる
即ち、ハイドロキシルアパタイトの前駆体であ
る燐酸カルシウム沈殿の結晶成長が、その際の温
度により強く影響されることである。 The above phenomenon was completely unexpected by the inventors at first, but based on these results, the formation mechanism is considered to be as follows. That is, the crystal growth of calcium phosphate precipitate, which is a precursor of hydroxylapatite, It is strongly influenced by the actual temperature.
燐酸カルシウム沈殿はその生成時の温度が、25
℃より上昇するに従つて次第に大きなブラツシヤ
イト(brushite)CaHPO4・2H2O結晶として成
長するが、45℃を頂点として、それ以上では逆に
ブラツシヤイト結晶は次第に微小化する。そし
て、80℃近辺から上では、微小ブラツシヤイトは
脱水されて微小なモネタイト(monetite)
CaHPO4の結晶となる。更に、温度が上昇して90
℃以上になると、生成燐酸カルシウム沈殿の粒子
径は突如として増大且つ硬化する。90℃を越える
温度での不連続的な変化は、この高温では発生期
の極微小ブラツシヤイト結晶が直ちに脱水されて
モネタイトになると同時に凝結して強固な粒子を
形成するものと考えられる。80〜90℃で生成した
モネタイト結晶、或いは市販のモネタイトにはこ
の凝結能はなく、微細結晶に止まる。 Calcium phosphate precipitate is formed at a temperature of 25
As the temperature rises above ℃, brushite CaHPO 4 2H 2 O crystals grow gradually larger, but after reaching a peak of 45 ℃, the brushite crystals gradually become smaller. Then, at temperatures above 80°C, minute brassyite is dehydrated and becomes minute monetite.
It becomes a crystal of CaHPO4 . Furthermore, the temperature rose to 90
When the temperature exceeds .degree. C., the particle size of the formed calcium phosphate precipitate suddenly increases and hardens. The discontinuous change at temperatures above 90°C is thought to be due to the fact that at this high temperature, the nascent, ultra-fine brassiaite crystals are immediately dehydrated and become monetite, which at the same time coagulates to form strong particles. Monetite crystals produced at 80 to 90°C or commercially available monetite do not have this ability to coagulate and remain in the form of fine crystals.
次にかくして生成させた燐酸カルシウム沈殿を
アルカリ中で加熱することによつてハイドロキシ
ルアパタイトに転移させるのであるが、従来、こ
の際、原材料の塩化カルシウム(CaCl2)1モル
に対し、1モル以上の割合の大量のアルカリが添
加されていた。 Next, the calcium phosphate precipitate thus generated is transformed into hydroxylapatite by heating in an alkali. Conventionally, at this time, 1 mole or more of calcium chloride (CaCl 2 ), which is the raw material, is converted into hydroxylapatite. A large amount of alkali was added in a proportion of .
本発明者はこれについても吟味を加えた結果、
アルカリ添加量を低減することが可能であり、原
材料のCaCl21モルに対して0.4〜0.6モルの割合、
最も好ましくは0.5モルの割合で苛性ソーダ
(NaOH)を添加するのが良いことを見出した。 As a result of careful consideration of this matter, the inventor found that
It is possible to reduce the amount of alkali added, at a ratio of 0.4 to 0.6 mol per 1 mol of CaCl 2 of the raw material,
It has been found that it is most preferable to add caustic soda (NaOH) in a proportion of 0.5 mole.
従来の方法では過剰のアルカリを除去するため
に大量の水乃至は燐酸塩緩衝液による洗浄を必要
としたが、本発明者がここに提案する方法による
時は製品の洗浄・仕上が著しく簡易化されるもの
である。 Conventional methods required washing with large amounts of water or phosphate buffer to remove excess alkali, but the method proposed by the present inventors greatly simplifies cleaning and finishing of products. It is something that will be done.
又製品のハイドロキシルアパタイトは従来、燐
酸塩緩衝液中に貯蔵されてきた。本発明の実施の
態様に於ても、勿論これを利用もするが、更に本
発明者はより便宜な態様をもこれに加えるもので
ある。 The product hydroxylapatite has also traditionally been stored in phosphate buffers. Of course, this is also utilized in the embodiments of the present invention, but the inventors have also added more convenient embodiments.
即ち、生成したハイドロキシルアパタイトを沸
騰温度以上220℃に至る温度で加熱乾燥しても、
分離剤としての良好な性能を保持したままで乾燥
粉粒体を得られることを見出した。 In other words, even if the produced hydroxylapatite is heated and dried at temperatures above the boiling temperature and up to 220°C,
It has been found that dry powder can be obtained while maintaining good performance as a separating agent.
乾燥製品は貯蔵・輸送に多大な便宜を与えるも
のである。 Dry products offer great storage and transportation convenience.
[実施例及び比較例]
以下、実施例及び比較例によつて、実施の態様
とその効果を具体的に示す。[Examples and Comparative Examples] Hereinafter, embodiments of implementation and effects thereof will be specifically shown by Examples and Comparative Examples.
比較例
0.5M(モル濃度)CaCl2水溶液及び0.5M
Na2HPO4水溶液の各々2を用意し、各々を毎
分2.5mlの割合で、所望の一定温度に保ち、且つ
可及的緩慢に撹拌しつつある1の0.5M NaCl
水溶液中に注入する。注入の間中混合溶液の温度
を上記一定値に維持せしめる。Comparative example 0.5M (molar concentration) CaCl 2 aqueous solution and 0.5M
Prepare 2 parts each of Na 2 HPO 4 aqueous solutions and add 1 part of 0.5M NaCl to each at a rate of 2.5 ml per minute while keeping the desired constant temperature and stirring as slowly as possible.
Inject into aqueous solution. The temperature of the mixed solution is maintained at the above constant value throughout the injection.
所望の一定温度として、25,40,45,55,70,
85及び95℃の各温度を採り上げて実験した。各実
験温度での操作によつて生成した燐酸カルシウム
沈殿を反応溶液から採取し、それぞれについて充
分に水洗し、5の0.25M NaOHに懸濁し、撹
拌しつつ1時間煮沸する。得られたハイドロキシ
ルアパタイトを70℃の温湯で良く洗い、次いで
10mM燐酸塩緩衝液(PH6.9)で洗つた後、同じ
緩衝液中に貯蔵する。 25, 40, 45, 55, 70, as the desired constant temperature.
Experiments were conducted using temperatures of 85 and 95°C. Calcium phosphate precipitates produced by the operation at each experimental temperature were collected from the reaction solution, each thoroughly washed with water, suspended in 0.25M NaOH (5), and boiled for 1 hour with stirring. The obtained hydroxylapatite was thoroughly washed with warm water at 70℃, and then
After washing with 10mM phosphate buffer (PH6.9), store in the same buffer.
各温度で生成された燐酸カルシウム由来のハイ
ドロキシルアパタイトの静止沈殿1mlを底にナイ
ロン網を置いた内径8.5mmのガラス円筒に充填し、
10mM燐酸塩緩衝液を水柱80cmの圧力下で通過さ
せてその流速を測定すると共に、ハイドロキシル
アパタイト層の落ち着き高さを観測し、その占め
る充填層体積V(ml)を計算した。 1 ml of static precipitate of hydroxylapatite derived from calcium phosphate produced at each temperature was filled into a glass cylinder with an inner diameter of 8.5 mm with a nylon mesh placed on the bottom.
A 10 mM phosphate buffer solution was passed under a pressure of 80 cm of water column, and the flow rate was measured, the settling height of the hydroxylapatite layer was observed, and the filled bed volume V (ml) occupied by the hydroxylapatite layer was calculated.
なお、上記流速測定値から水柱1cm圧、充填層
高1cm当りの値を計算し、これを基準化流速U
(ml/min/cm/cmHH)で示す。 In addition, from the above flow rate measurement value, calculate the value per 1 cm of water column pressure and 1 cm of packed bed height, and use this as the normalized flow rate U.
It is expressed in (ml/min/cm/cmHH).
また、10mM燐酸塩緩衝液に仔牛胸腺DNAを
100μg/mlの濃度に含む溶液を水柱80cmの圧力
下で流し、カラムからの排出液中にDNAが検知
される迄の通液量からDNA吸着量C(mg)を算出
した。 Additionally, calf thymus DNA was added to 10mM phosphate buffer.
A solution containing a concentration of 100 μg/ml was flowed under a pressure of 80 cm of water column, and the DNA adsorption amount C (mg) was calculated from the amount of flow until DNA was detected in the liquid discharged from the column.
各ハイドロキシルアパタイトの前駆体である燐
酸カルシウム沈殿を生成した温度を横軸に取り、
対応するハイドロキシルアパタイト試料による落
ち着き充填層体積V、基準化流速U、並びに
DNA吸着量Cを縦軸に取つて画いたグラフが第
1図である。 The temperature at which calcium phosphate precipitate, which is the precursor of each hydroxylapatite, is formed is taken on the horizontal axis.
The settled packed bed volume V, the normalized flow rate U, and the corresponding hydroxylapatite sample
FIG. 1 is a graph plotting the amount of DNA adsorption C on the vertical axis.
図に見る通り落着充填層体積V、ならびに基準
化流速Uが、前駆体である燐酸カルシウムの生成
温度によつて大きく異なることが明らかとなつ
た。 As shown in the figure, it has become clear that the settled packed bed volume V and the normalized flow rate U vary greatly depending on the formation temperature of the calcium phosphate precursor.
そして45℃および95℃で生成した燐酸カルシウ
ムからのハイドロキシルアパタイト(以下それぞ
れH45,H95と略記)で極大が見られる。 The maximum is seen in hydroxylapatite from calcium phosphate (hereinafter abbreviated as H45 and H95, respectively) produced at 45°C and 95°C.
殊に流速に於て大巾な違いが生じ、チセリウス
が提示し、従来用いられてきた室温付近の25℃で
生成された燐酸カルシウムからのハイドロキシル
アパタイト(以下H25と略記)のそれの10倍にも
達つしている。 In particular, there is a large difference in flow rate, which is 10 times that of hydroxylapatite (hereinafter abbreviated as H25) from calcium phosphate produced at 25℃, which is around room temperature, as proposed by Chiselius. It has also reached
これはH45,H95が粒子径が大きく、しかもカ
ラム充填に於て、殆ど圧縮されないことを示唆す
る。一方DMA吸着量は70〜85℃生成燐酸カルシ
ウムからのハイドロキシルアパタイトに於て低い
がそれ以外は殆ど変わらず、特に本発明で焦点と
なつている45℃と95℃は25℃の場合と同等以上の
能力を保有ししていることが判る。 This suggests that H45 and H95 have large particle sizes and are hardly compressed when packed in a column. On the other hand, the amount of DMA adsorption is lower in hydroxylapatite produced from calcium phosphate produced at 70 to 85°C, but other than that there is almost no difference.Especially at 45°C and 95°C, which are the focus of this invention, it is equivalent to the case at 25°C. It is clear that he possesses the above abilities.
なお又、H25,H45及びH95の各ハイドロキシ
ルアパタイトを充填したカラムについて蛋白質と
して仔牛血清アルブミンを、RNAとして酵母リ
ボ核酸を、DNAとして仔牛胸腺デオキシリボ核
酸を展開した成績を第2図に示すが、H45,H95
は両者共に従来法のH25と変わらない分離・分画
精度を達することが確認される。 Furthermore, Figure 2 shows the results of developing calf serum albumin as protein, yeast ribonucleic acid as RNA, and calf thymus deoxyribonucleic acid as DNA for columns packed with H25, H45, and H95 hydroxylapatite. H45, H95
It is confirmed that both methods achieve the same separation and fractionation accuracy as the conventional method H25.
実施例 1
0.5M(モル濃度)CaCl2と0.5M Na2HPO4の水
溶液を各2用意し、45℃に保つて可及的緩慢に
撹拌しつつある1の0.5M NaCl水溶液中に
各々毎分2.5mlの割合で注入して混合、反応させ
る。生成した燐酸カルシウム(ブラツシヤイト)
の大きな結晶をよく水洗して1の水に懸濁し、
100mlの10M NaOHを加えて1時間煮沸する。
得られたハイドロキシルアパタイトを水及び燐酸
緩衝液で良く洗浄し、使用迄そのまま貯蔵する。Example 1 Two aqueous solutions of 0.5M (molar concentration) CaCl 2 and 0.5M Na 2 HPO 4 were prepared, and each was added to one 0.5M NaCl aqueous solution kept at 45°C and stirred as slowly as possible. Inject at a rate of 2.5 ml per minute, mix, and react. Calcium phosphate (brassiaite) produced
Wash the large crystals thoroughly with water and suspend them in water of 1.
Add 100ml of 10M NaOH and boil for 1 hour.
The obtained hydroxylapatite is thoroughly washed with water and phosphate buffer and stored as is until use.
実施例 2
0.5M(モル濃度)CaCl2と0.5M Na2HPO4の水
溶液を各2用意し、95〜100℃に保つて可及的
緩慢に撹拌しつつある1の0.5M NaCl水溶液
中に各々毎分2.5mlの割合で注入して混合、反応
させる。生成した燐酸カルシウム(モネタイト)
の大きく硬い粒子をよく水洗して1の水に懸濁
し、100mlの5M NaOHを加えて1時間煮沸す
る。得られたハイドロキシルアパタイトは水で洗
浄し、貯蔵する。Example 2 Two aqueous solutions of 0.5M (molar concentration) CaCl 2 and 0.5M Na 2 HPO 4 were prepared and poured into one 0.5M NaCl aqueous solution kept at 95-100°C and stirred as slowly as possible. Inject each at a rate of 2.5 ml per minute to mix and react. Calcium phosphate (monetite) produced
Wash the large, hard particles thoroughly with water, suspend them in 1 water, add 100 ml of 5M NaOH, and boil for 1 hour. The obtained hydroxylapatite is washed with water and stored.
実施例 3
実施例2と同様に操作して得た湿つたハイドロ
キシルアパタイトを加熱し、乾燥する。Example 3 Wet hydroxylapatite obtained in the same manner as in Example 2 is heated and dried.
最終温度を220℃に至らしめ、乾燥粉末を得る。 The final temperature is reached at 220°C to obtain a dry powder.
(3) 発明の効果
本発明の特許請求の範囲1、並びに2、記載の
方法によれば、生体高分子物質の分離用クロマト
グラフ充填剤として優れた分離・分画精度を持
ち、しかも、高い展開液流速が可能なことによつ
て迅速に作業を進められる、分離用ハイドロキシ
ルアパタイトが調製できる。(3) Effects of the invention According to the method described in claims 1 and 2 of the present invention, it has excellent separation and fractionation accuracy as a chromatographic packing material for separating biopolymer substances, and also has high Hydroxylapatite for separation can be prepared quickly due to the high flow rate of the developing solution.
第1図はハイドロキシルアパタイト前駆体であ
る燐酸カルシウムを生成する際の温度とそれから
導かれたハイドロキシルアパタイトの性能との関
係を示す。
図中V及びCはハイドロキシルアパタイト静止
沈殿1ml当りのカラム充填後の体積(ml)並びに
吸着DNA量(mg)をそれぞれ示し、Uは展開液
基準化流速(ml/min/cm/cmHH)を示す。第
2図はH45,H95並びに比較としてH25を充填し
たカラムによる仔牛血清アルブミン(P)、酵母
リボ核酸(R)及び仔牛胸腺デオキシリボ核酸
(D)についてのクロマト分画パターンを示す。
FIG. 1 shows the relationship between the temperature at which calcium phosphate, which is a hydroxylapatite precursor, is produced and the performance of hydroxylapatite derived therefrom. In the figure, V and C indicate the volume after column filling (ml) and adsorbed DNA amount (mg) per 1 ml of hydroxylapatite static precipitation, respectively, and U indicates the developing solution standardized flow rate (ml/min/cm/cmHH). show. FIG. 2 shows chromatographic fractionation patterns for calf serum albumin (P), yeast ribonucleic acid (R), and calf thymus deoxyribonucleic acid (D) using columns packed with H45, H95, and H25 for comparison.
Claims (1)
液とを40℃乃至50℃の温度範囲、最も好ましくは
45℃の温度において混合し、得られる燐酸カルシ
ウム沈殿をアルカリ中で加熱してハイドロキシル
アパタイトとすることを特徴とする分離用ハイド
ロキシルアパタイトの製法。 2 塩化カルシウム溶液と第二燐酸ナトリウム溶
液とを90℃乃至100℃の温度範囲、最も好ましく
は95℃の温度において混合し、得られる燐酸カル
シウム沈殿をアルカリ中で加熱してハイドロキシ
ルアパタイトとすることを特徴とする分離用ハイ
ドロキシルアパタイトの製法。[Claims] 1. Calcium chloride solution and dibasic sodium phosphate solution are heated in a temperature range of 40°C to 50°C, most preferably
A method for producing hydroxylapatite for separation, which comprises mixing at a temperature of 45°C and heating the resulting calcium phosphate precipitate in an alkali to produce hydroxylapatite. 2. Mixing a calcium chloride solution and a dibasic sodium phosphate solution at a temperature range of 90°C to 100°C, most preferably at a temperature of 95°C, and heating the resulting calcium phosphate precipitate in an alkali to form hydroxylapatite. A method for producing hydroxylapatite for separation, which is characterized by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61015900A JPS62176906A (en) | 1986-01-29 | 1986-01-29 | Manufacturing method of hydroxylapatite for separation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61015900A JPS62176906A (en) | 1986-01-29 | 1986-01-29 | Manufacturing method of hydroxylapatite for separation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62176906A JPS62176906A (en) | 1987-08-03 |
| JPH0479964B2 true JPH0479964B2 (en) | 1992-12-17 |
Family
ID=11901653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61015900A Granted JPS62176906A (en) | 1986-01-29 | 1986-01-29 | Manufacturing method of hydroxylapatite for separation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62176906A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0624963B2 (en) * | 1989-08-01 | 1994-04-06 | 東亞合成化学工業株式会社 | Method for producing hydroxyapatite |
| JP5506190B2 (en) * | 2008-12-26 | 2014-05-28 | 愛知県 | Protein remover for brewing sake |
-
1986
- 1986-01-29 JP JP61015900A patent/JPS62176906A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62176906A (en) | 1987-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4667018A (en) | Process for the purification of proteins using acidic polysaccharide gels | |
| JPS6291410A (en) | Calcium phosphate hydroxyapatite for chromatographic separation and its production | |
| EP1314467B1 (en) | Composite chromatographic sorbent of mineral oxide beads with hydroxyapatite-filled pores | |
| CN105921103B (en) | A kind of while fixed nitrogen phosphorus La (OH)3The preparation method of modification infusorial earth-molecular sieve sorbing material | |
| JPH0337706B2 (en) | ||
| US5229096A (en) | Silica gel | |
| CN87102573A (en) | The liquid-phase chromatographic column of hydroapatite particles aggregation and this aggregation of employing | |
| JPH0479964B2 (en) | ||
| JPH0615427B2 (en) | Inorganic porous body and method for producing the same | |
| JPH0624963B2 (en) | Method for producing hydroxyapatite | |
| JPH04118047A (en) | Adsorbent and filler for separation and refining and manufacture thereof | |
| KR20000049200A (en) | Porous inorganic composition and method for separating metal element using the same | |
| JP4222853B2 (en) | Method for producing alkali-resistant chemically modified silica gel | |
| JPH0259415A (en) | Production of silica gel having hydrophobic inside surface | |
| JPH0786506B2 (en) | Packing material for liquid chromatography | |
| RU2218303C2 (en) | Method to produce synthetic zeolite of a-type | |
| JP2564150B2 (en) | Synthetic calcium silicate hydrate | |
| JPH0665635B2 (en) | Molding material | |
| JPH0516368B2 (en) | ||
| JPH01155263A (en) | Filler for liquid chromatography and preparation thereof | |
| JPS63157973A (en) | Liquid chromatography | |
| SU681837A1 (en) | Method of immobilizing protein molecules | |
| JP3352757B2 (en) | Packing material for liquid chromatography | |
| RU2218304C2 (en) | Method to produce synthetic zeolite of x-type | |
| JPS61266306A (en) | Fine spherical particle of crystalline aluminosilicate and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |